COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
Jack joined the Burnet Institute in 2019 to work on multiple projects in the Eliminate Hepatitis C Partnership.
He completed his honours with the Burnet in 2017. His thesis explored pathways to increase access to hepatitis C treatment in pharmacies that provide opioid substitution therapy.
Jack has interests in both qualitative and quantitative research, AOD harm reduction, mental health, and blood-borne viruses.